Literature DB >> 19019447

Intraocular pressure and corneal biomechanical properties in patients with myotonic dystrophy.

Nicola Rosa1, Michele Lanza, Maria Borrelli, Alberto Palladino, M Grazia Di Gregorio, Luisa Politano.   

Abstract

PURPOSE: To compare intraocular pressure (IOP) between patients with myotonic dystrophy (DM1) and normal subjects, taking into account corneal characteristics. To determine whether lower IOP measurements in patients with DM1 are due to thinner corneas.
DESIGN: Comparative case series. PARTICIPANTS: Fifty-three eyes of patients with DM1 and 53 eyes of normal age- and sex-matched subjects.
METHODS: Corneal biomechanical properties and corneal compensated intraocular pressure (IOPcc) measured with the Ocular Response Analyzer (Reichert Inc., Depew, NY), central corneal thickness measured with the Oculus Pentacam (Oculus, Wetzlar, Germany), and IOP were evaluated in patients with DM1 and compared with age- and sex-matched healthy subjects. MAIN OUTCOME MEASUREMENTS: Goldmann applanation tonometry, central corneal thickness, corneal hysteresis (CH), corneal resistance factor (CRF), and IOPcc.
RESULTS: Compared with the healthy subjects, patients with DM1 showed lower IOP (12.4+/-3.6 mm Hg vs. 14.9+/-3.4 mmHg) (P<0.01) and IOPcc (12.7+/-4.5 vs. 15.9+/-3.5) (P<0.01), and thicker cornea (575.9+/-35.02 mum vs. 556.3+/-33.2 microm) (P<0.01), but no significant changes in CH (P = 0.03) and CRF (P = 0.37).
CONCLUSIONS: Lower IOP in patients with DM1 is not related to differences in central corneal thickness or corneal biomechanical properties. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

Entities:  

Mesh:

Year:  2008        PMID: 19019447     DOI: 10.1016/j.ophtha.2008.09.001

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  8 in total

1.  Intraocular pressure after LASEK.

Authors:  Maddalena De Bernardo; Nicola Rosa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-20       Impact factor: 3.117

2.  Epiretinal membrane: a treatable cause of visual disability in myotonic dystrophy type 1.

Authors:  Hannah M Kersten; Richard H Roxburgh; Nicholas Child; Philip J Polkinghorne; Chris Frampton; Helen V Danesh-Meyer
Journal:  J Neurol       Date:  2013-10-17       Impact factor: 4.849

3.  Fuchs endothelial corneal dystrophy in patients with myotonic dystrophy: a case series.

Authors:  Devin Gattey; Angela Y Zhu; Anna Stagner; Mark A Terry; Albert S Jun
Journal:  Cornea       Date:  2014-01       Impact factor: 2.651

4.  Central corneal thickness measurement with different devices in keratoconic patients.

Authors:  Maddalena De Bernardo; Nicola Rosa
Journal:  J Curr Ophthalmol       Date:  2017-12-06

5.  Central corneal thickness measurement with Cirrus HD-OCT and Topcon SP-3000P.

Authors:  Maddalena De Bernardo; Francesco Antonio Salzano; Nicola Rosa
Journal:  J Optom       Date:  2017-12-14

6.  Fuchs' Endothelial Corneal Dystrophy in Patients With Myotonic Dystrophy, Type 1.

Authors:  Nelson S Winkler; Margherita Milone; Jennifer M Martinez-Thompson; Harish Raja; Ross A Aleff; Sanjay V Patel; Michael P Fautsch; Eric D Wieben; Keith H Baratz
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-06-01       Impact factor: 4.799

7.  Corneal Thickness Measurement after Hyperopic Photorefractive Keratectomy.

Authors:  Maddalena De Bernardo; Nicola Rosa
Journal:  J Ophthalmic Vis Res       Date:  2018 Jul-Sep

8.  Efficacy and safety of ropivacaine HCl in peribulbar anaesthesia for cataract surgery in patients with myotonic dystrophy type 1.

Authors:  Alberto Palladino; Maddalena De Bernardo; Marianna Scutifero; Michele Lanza; Silvio De Querquis; Nicola Rosa; Luisa Politano
Journal:  Acta Myol       Date:  2020-06-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.